ARSEUS Share Price Euronext Amsterdam
Stocks
BE0003874915
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Euronext Amsterdam
|
||
| - EUR | - |
|
| 08-01 | Fagron NV, H1 2026 Earnings Call, Jul 30, 2026 | |
| 07-30 | Fagron NV Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 1.57B 1.83B 1.48B 1.35B 2.52B 174B 2.53B 17.51B 6.77B 88.72B 6.86B 6.71B 280B | P/E 2026 * |
14.7x | P/E 2027 * | 13.1x |
|---|---|---|---|---|---|
| Enterprise Value | 2.08B 2.42B 1.96B 1.79B 3.34B 230B 3.35B 23.2B 8.97B 118B 9.08B 8.89B 371B | EV / Sales 2026 * |
1.82x | EV / Sales 2027 * | 1.63x |
| Free-Float |
71.36% | Yield 2026 * |
1.99% | Yield 2027 * | 2.13% |
Last Transcript : ARSEUS
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 48 | 26/11/2017 | |
Karin de Jong
DFI | Director of Finance/CFO | 47 | 30/04/2016 |
Vera Bakker
COO | Chief Operating Officer | 54 | 08/05/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Karin de Jong
BRD | Director/Board Member | 47 | 30/04/2016 |
Koen Hoffman
CHM | Chairman | 58 | 08/05/2017 |
| Director/Board Member | 48 | 06/02/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.03% | -3.09% | +52.20% | +91.69% | 1,002B | |
| -0.76% | -1.52% | +49.94% | +66.34% | 649B | |
| +0.86% | -3.49% | +19.60% | +68.37% | 440B | |
| -0.80% | +0.06% | +28.73% | +35.45% | 346B | |
| -0.13% | -14.74% | +9.13% | +26.71% | 263B | |
| -1.90% | -2.61% | -2.67% | +7.41% | 250B | |
| -0.48% | -10.69% | +39.64% | +50.82% | 213B | |
| -1.06% | -1.70% | -16.73% | -57.36% | 201B | |
| -0.68% | -2.85% | +25.69% | +91.64% | 182B | |
| Average | -0.40% | -2.06% | +22.84% | +42.34% | 393.74B | |
| Weighted average by Cap. | -0.08% | -2.39% | +32.37% | +57.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.14B 1.33B 1.07B 979M 1.83B 126B 1.84B 12.72B 4.92B 64.46B 4.98B 4.87B 204B | 1.24B 1.44B 1.17B 1.06B 1.99B 137B 2B 13.83B 5.34B 70.06B 5.41B 5.3B 221B |
| Net income | 107M 124M 101M 91.73M 172M 11.83B 172M 1.19B 461M 6.04B 467M 457M 19.07B | 119M 139M 113M 103M 192M 13.23B 193M 1.33B 515M 6.75B 522M 510M 21.32B |
| Net Debt | 510M 594M 480M 438M 819M 56.47B 822M 5.69B 2.2B 28.83B 2.23B 2.18B 91.03B | 450M 524M 424M 386M 722M 49.8B 725M 5.02B 1.94B 25.43B 1.97B 1.92B 80.29B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
